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osting by EAbstract The present study was designed to investigate the antihypertensive and antioxidant effect
ofMelothria maderaspatana leaf extract (MME) on sham-operated and DOCA-salt (deoxycorticos-
terone acetate) induced hypertensive rats. Administration of DOCA-salt signiﬁcantly increased the
systolic (from 127 to 212 mm Hg) and diastolic (from 91 to 174 mm Hg) blood pressure compared
to sham-operated control rats, while treatment with MME signiﬁcantly reduced the systolic (from
212 to 135 mm Hg) and diastolic (from 174 to 96 mm Hg) blood pressure compared to hypertensive
control. In DOCA-salt rats, the plasma and tissue concentration of thiobarbituric acid reactive sub-
stances (TBARS) and lipid hydroperoxide (LOOH) signiﬁcantly increased and administration of
MME signiﬁcantly reduced these parameters towards the levels in sham-operated control. In hyper-
tensive rats, activities of the enzymatic antioxidants such as superoxide dismutase (SOD), catalase
(CAT) and glutathione peroxidase (GPx) and levels of non-enzymatic antioxidants such as vitamin
C, vitamin E and reduced glutathione (GSH) decreased signiﬁcantly in the plasma and tissues.
Administration of MME returned the enzymatic and non-enzymatic antioxidants towards sham-
operated control. MME shows both antihypertensive and antioxidant properties in DOCA-salt144 238343; fax: +91 4144
K.V. Pugalendi).
ity. All rights reserved. Peer-
d University.
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100 C. Veeramani et al.hypertensive rats and, among the three different doses tested, 200 mg/kg caused the maximum
effect.
ª 2010 King Saud University. All rights reserved.1. Introduction
Hypertension is a well-deﬁned risk factor for cardiovascular
diseases and recent analyses show that it is the single most
important cause of strokes and coronary heart disease (Touyz
and Schiffrin, 2004; Beswick et al., 2001) In hypertensive ani-
mals, ROS are increased and superoxide dismutase, which con-
verts O2 to H2O2, is reduced, suggesting that an imbalance
between oxidant and antioxidant mechanisms is a contributing
factor (Beswick et al., 2001; Thakali et al., 2006). ROS play an
important role in several responses involved in vascular
remodeling, including proliferation, migration, and hypertro-
phy (Beswick et al., 2001; Taniyama and Griendling, 2003).
Therefore, ROS have been implicated in the pathogenesis of
vascular disease, including atherosclerosis, apoptosis and
hypertension. The long-term administration of DOCA-salts
to rats induces sodium retention and high salt intake, produc-
ing volume-dependent hypertension (Hollenberg et al., 1992).
This experimental model of hypertension is also associated
with an increase in vascular superoxide anion generation and
altered endothelium-dependent vascular relaxation (Wu
et al., 2001). The heart, kidney and blood vessels are all impli-
cated in hypertension; consequences of exposure to oxidative
stress may include myocardial and renal hypertrophy (Sawyer
et al., 2002) and endothelial dysfunction (McIntyre et al.,
1999).
Traditional medicine has demonstrated its contribution
to the reduction of excessive mortality, morbidity and dis-
ability due to diseases such as hypertension, hepatotoxicity
and diabetes. In India, the different traditional medicine
systems make use of a number of plants in the treatment
of hypertension. Melothria maderaspatana (L.) is one such
medicinal plant popularly used for the treatment of hyper-
tension in traditional practice (Cooke, 1967). Decoctions of
leaves of M. Maderaspatana have been used for the treat-
ment of live stock diseases such as adenitis, proplasmosis,
theileriasis, plague, anthrax, rabies, madness and anaplas-
mosis (Jayaweera, 1982). This plant leaf extract have also
shown to have hepatoprotective (Jayathilaka et al., 1990),
immunomodulatory effect and antiarthritic activity proper-
ties. Therefore, in the present study the main aim was to
investigate the effects of MME on blood pressure antioxi-
dants status on DOCA-salt hypertensive rats and to com-
pare such effects with those of the calcium channel
blocker nifedipine.
2. Materials and methods
2.1. Preparation of leaf extract
Leaf powder ofM. maderaspatana was purchased from the lo-
cal herbal market (Vinayaga herbals), Chidambaram, Cudda-
lore district, Tamil Nadu, India. The leaf powder was sieved
and kept in deep freezer until use. 100 g of dry ﬁne powder
was suspended in 300 ml of ethanol for 72 h. The extract wasﬁltered using a muslin cloth and concentrated at 40 ± 5 C.
The extract was kept in deep freezer until use.
2.2. Animals
Male albino Wistar rats (weighing 200–230 g) were pur-
chased from the Central Animal House, Department of
Experimental Medicine, Rajah Muthiah Medical College
and Hospital, Annamalai University, and maintained in an
air-conditioned room (25 ± 1 C) with a 12 h light/12 h dark
cycle. Feed and water were provided ad libitum. The exper-
imental study was approved by the Ethical Committee of
Rajah Muthiah Medical College and Hospital (Reg
No.160/1999/CPCSEA, Proposal No.444), Annamalai Uni-
versity, Annamalainagar.
2.3. Chemicals
DOCA-salt was obtained from Sigma–Aldrich Company (St.
Louis, Missouri, USA). All other chemicals used were of ana-
lytical grade obtained from E. Merck or HIMEDIA, Mumbai,
India.
2.4. Method of uninephrectomy
Animals were anesthetized by an intraperitonial injection of
ketamine (75 mg/kg BW). A small patch of skin above the left
kidney was shaved, cleaned and applied with iodine based anti-
septic. 1 cm incisions were made at midscapular region. The
kidney was freed from the surrounding tissues and pulled
out gently. The adrenal glands, which is attached loosely to
the anterior pole of the kidney by connective tissue and fat,
was gently freed by tearing the attachments, and was put back
into the abdominal cavity. The renal artery and ureter were
tied by silk thread, and then the kidney was removed. The
muscle and skin layers were closed separately by using a chro-
mic sterile absorbable suture.
2.5. Experimental induction of hypertension
Animals were given weekly twice subcutaneous injections of
DOCA-salt (25 mg/kg BW) in dimethyl formamide (vehicle)
solution and salt was administered by substitution of 1% NaCl
solution for drinking water ad libitum throughout the experi-
mental period.
2.6. Experimental design
The rats were randomly divided into six groups of six rats
each. Group one served as sham-operated control and group
two served as hypertensive control. Groups III to V were
hypertensive rats which received different doses of MME 50,
100 and 200 mg/kg BW and group VI received nifedipine
20 mg/kg BW. MME or nifedipine were administered orally
once a day for 6 weeks between 9:00 a.m. and 10:00 a.m.
Effects of Melothria maderaspatana leaf extract on antioxidant status in sham-operated 101Group I: Sham-operated control (0.5% DMSO).
Group II: Sham-operated +DOCA-salt + 1%NaCl control.
Group III: Sham-operated + DOCA (25 mg/kg BW) + 1%
NaCl.
Group IV: Sham-operated + DOCA-salt + 1%
NaCl + 50 mg/kg BW MME in 0.5% DMSO.
Group V: Sham-operated + DOCA-salt + 1%
NaCl + 100 mg/kg BW MME in 0.5% DMSO.
Group VI: Sham-operated + DOCA-salt + 1%
NaCl + 200 mg/kg BW MME in 0.5% DMSO.
Group VII: Sham-operated + DOCA-salt + 1%
NaCl + 20 mg/kg BW nifedipine in 0.5% DMSO.
After 6 weeks, the animals were anaesthetized between 8:00
a.m. and 9:00 a.m. using ketamine (24 mg/kg BW, intramuscu-
lar injection) and sacriﬁced by cervical dislocation. Blood was
collected in tubes with a mixture of EDTA for the estimation
biochemical markers.
2.7. Blood pressure measurements
Systolic and diastolic blood pressures were determined by the
tail-cuff method (IITC, model 31, Woodland Hills, CA,
USA). The animals were placed in a heated chamber at an
ambient temperature of 30–34 C for 15 min and from each
animal, 1–9 blood pressure values were recorded. The lowest
three readings averaged to obtain a mean blood pressure. All
recordings and data analyses were done using a computerized
data acquisition system and software.
2.8. Biochemical analysis
The concentration of TBARS was estimated by the method of
Niehaus and Niehaus and Samuelson, 1968, Lipid hydroperox-
ide was estimated by the method of Jiang et al., 1992. The
activities of enzymatic antioxidants SOD, CAT and GPx were
measured by the method of Kakkar et al., 1984; Sinha, 1972
and Rotruck et al., 1973, respectively. The non-enzymatic anti-
oxidants GSH, vitamin C and vitamin E were estimated by the
method of Ellman (1959), Roe and Kuether (1943) and Baker
et al. (1980), respectively.
2.9. Statistical analysis
Statistical evaluation was performed using a one-way analysis
of variance (ANOVA), followed by Duncan’s multiple range
test (DMRT) using the statistical package of social science
(SPSS) version 10.0. The signiﬁcance level was set at p< 0.05.Table 1 Effect of Melothria maderaspatana leaf extract (MME) on
uninephrectomized DOCA-salt hypertensive rats.
Name of the group Systolic blo
0th day
Sham-operated control 120.67 ± 6.
DOCA-salt + 1% NaCl control 117.83 ± 4.
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 120.17 ± 3.
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 115.83 ± 4.
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 120.67 ± 4.
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 118.00 ± 5.
Values are means ± SD for six rats. Values not sharing a common super3. Results
Table 1 shows the effect of MME at three different doses (50,
100 and 200 mg/kg BW) on systolic and diastolic blood pres-
sure in sham-operated and DOCA-salt hypertensive rats. The
DOCA-salt rats signiﬁcantly increased the systolic and dia-
stolic blood pressure while treatment with MME or nifedipine
signiﬁcantly reduced the systolic and diastolic blood pressure
and the effect was more pronounced at 200 mg/kg BW dose.
There was no signiﬁcant difference between MME and nifedi-
pine on blood pressure.
Tables 2 and 3 show the effect of MME on the levels of
TBAR and LOOH in the plasma and tissues of sham-operated
and DOCA-salt hypertensive rats. The DOCA-salt rats exhib-
ited a signiﬁcant increase in the level of TBARS and LOOH.
The administration of MME or nifedipine reduced the levels
of TBARS and LOOH signiﬁcantly and the effect was more
pronounced at 200 mg/kg BW dose. Compared with nifedi-
pine, MME showed better effect.
Tables 4–6 show the effect of MME on the activities of
SOD, CAT and GPx in the erythrocyte and tissues of sham-
operated and DOCA- salt hypertensive rats. The activities of
SOD, CAT and GPx decreased signiﬁcantly in DOCA-salt rats
and the administration of MME or nifedipine signiﬁcantly in-
creased these parameters with a maximum at 200 mg/kg BW.
The MME showed better effect compared with nifedipine.
Tables 7–9 show the effect of MME on GSH, vitamin C
and E levels in the plasma and tissues of sham-operated and
DOCA-salt hypertensive rats. The levels of GSH, vitamin C
and E decreased signiﬁcantly in DOCA-salt rats and adminis-
tration of MME or nifedipine increased signiﬁcantly all these
parameters with a maximum at 200 mg/kg BW. The MME
showed better effect compared with nifedipine.
4. Discussion
The long-term administration of DOCA-salt induces sodium
retention and in the presence of a high salt, it produces vol-
ume-dependent type of hypertension in rats (Zhou et al.,
2008). In the present study, the DOCA-salt rats signiﬁcantly
increased the systolic and diastolic blood pressure. Oral
administration of MME or nifedipine resulted in a signiﬁcant
reduction in systolic and diastolic blood pressure. Triterpenes
are one of the most numerous and widespread group of pheno-
lic compounds in higher plants (Ohara and Ohira, 2003).
Recent studies have shown that phenolic phytochemicals have
high antioxidant (Vattem et al., 2005), antihypertensive and
anti-diabetic activity (Kwon et al., 2006). The plant leafthe systolic and diastolic blood pressure of sham-operated and
od pressure (mm Hg) Diastolic blood pressure (mm Hg)
6th week 0th day 6th week
42 127.17 ± 7.18a 81.83 ± 4.50 91.00 ± 4.84a
50 212.00 ± 9.51b 87.50 ± 3.75 174.67 ± 8.89b
82 192.67 ± 9.20c 88.17 ± 5.34 160.83 ± 9.28c
85 172.67 ± 7.00d 86.67 ± 4.44 140.67 ± 7.31d
64 135.50 ± 7.48a 84.20 ± 4.68 96.33 ± 6.08a
04 131.67 ± 7.80a 87.67 ± 4.45 93.50 ± 4.51a
script differ signiﬁcantly at p< 0.05 (DMRT).
Table 2 Effect of MME on TBARS in the plasma and tissues of sham-operated and uninephrectomized DOCA-salt hypertensive rats.
Name of the group Plasma (mmol/dL) TBARS (mmol/100 g wet tissue)
Liver Kidney Heart
Sham-operated control 0.153 ± 0.014a 0.854 ± 0.062a 1.450 ± 0.122a 0.525 ± 0.042a
DOCA-salt + 1% NaCl control 0.445 ± 0.035b 2.600 ± 0.151b 4.000 ± 0.338b 3.175 ± 0.157b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 0.395 ± 0.025c 2.050 ± 0.145c 3.350 ± 0.235c 2.850 ± 0.122c
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 0.320 ± 0.020c 1.950 ± 0.134d 2.750 ± 0.205d 1.450 ± 0.122d
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 0.165 ± 0.014a 0.905 ± 0.073a,d 1.525 ± 0.125a,e 0.600 ± 0.054a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 0.180 ± 0.023a 1.030 ± 0.122d 1.775 ± 0.147e 0.825 ± 0.063a,e
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT).
Table 3 Effect of MME on lipid hydroperoxide in the plasma and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Plasma (mmol/dL) LOOH (mmol/100 g wet tissue)
Liver Kidney Heart
Sham-operated control 9.16 ± 0.89a 78.57 ± 4.51a 65.48 ± 6.20a 69.64 ± 6.68a
DOCA-salt + 1% NaCl control 20.47 ± 1.31b 99.07 ± 8.78b 170.24 ± 8.04b 139.88 ± 11.38b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 18.51 ± 1.18c 96.33 ± 8.35b,c 148.81 ± 10.02c 120.83 ± 11.60c
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 15.83 ± 1.50d 91.78 ± 7.74b,c,d 119.05 ± 9.22d 107.14 ± 5.05d
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 10.65 ± 0.82a 82.52 ± 5.83a,d 70.83 ± 6.15a 72.02 ± 6.15a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 13.50 ± 1.12e 86.97 ± 4.74a,c,d 75.95 ± 5.00a 77.05 ± 6.25a
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT).
Table 4 Effect of MME on activities of SOD in the erythrocyte and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Erythrocyte (U/mg Hb) SOD (U/mg protein)
Liver Kidney Heart
Sham-operated control 7.47 ± 0.43a 7.94 ± 0.47a 14.48 ± 1.54a 5.10 ± 0.34a,d
DOCA-salt + 1% NaCl control 3.09 ± 0.30b 4.21 ± 0.34b 8.55 ± 0.84b 2.81 ± 0.12b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 3.80 ± 0.23c 4.47 ± 0.41b 8.35 ± 0.83b 3.15 ± 0.23b,c
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 4.20 ± 0.21c 5.51 ± 0.46c 10.39 ± 1.37c 3.62 ± 0.29c
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 6.93 ± 0.52a 6.96 ± 0.59a 12.91 ± 1.68a 4.83 ± 0.47a,d
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 6.49 ± 0.57a 5.66 ± 0.43c,a 12.35 ± 0.96a 4.24 ± 0.22d
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT). U= enzyme con-
centration required to inhibit the chromogen produced by 50% in one min under standard condition.
Table 5 Effect of MME on activities of CAT in the erythrocyte and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Erythrocyte (U/mg Hb) CAT (U/mg protein)
Liver Kidney Heart
Sham-operated control 168.90 ± 8.03a 76.99 ± 6.87a 31.99 ± 2.43a 48.57 ± 3.71a,d
DOCA-salt + 1% NaCl control 97.26 ± 6.40b 52.81 ± 3.16b 18.07 ± 1.02b 28.19 ± 2.40b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 108.80 ± 8.40b 56.06 ± 3.11b,c 19.72 ± 0.88b 33.86 ± 2.62c
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 124.88 ± 10.09c 60.32 ± 3.48c 22.89 ± 1.87c 36.03 ± 1.81c,d
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 160.26 ± 10.53a,d 72.47 ± 6.67a,d 28.04 ± 1.72d 44.86 ± 2.52e
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 153.59 ± 9.49d 68.08 ± 4.28d 24.29 ± 2.45c 39.30 ± 3.25d
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT). U= lmol of H2O2
consumed/min.
102 C. Veeramani et al.possesses coumarine (a triterpene) have many pharmacological
activities such as anti-clotting ( Suttie, 1987), hypotensive
(Huang et al., 1992) and anti-inﬂammatory activities (Payaet al., 1992). The signiﬁcant reduction of blood pressures in
DOCA-salt rats may be due to one or few of the active princi-
ples of the leaf extract. Furthermore, it has been suggested that
Table 6 Effect of MME on activities of GPx in the erythrocyte and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Erythrocyte (U/mg Hb) GPx (U/mg protein)
Liver Kidney Heart
Sham-operated control 15.47 ± 1.33a 7.25 ± 0.52a 8.11± 0.47a 6.93 ± 0.48a
DOCA-salt + 1% NaCl control 6.64 ± 0.45b 4.48 ± 0.40b 3.52 ± 0.35b 3.73 ± 0.74b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 8.43± 0.57b 4.80 ± 0.35b 4.16 ± 0.35c 3.95 ± 0.26b,c
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 10.06 ± 0.55c 5.44 ± 0.35c 5.33 ± 0.53d 4.16 ± 0.35b,c
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 13.95 ± 1.26d 7.02 ± 0.30a 7.15 ± 0.64a,d 5.98 ± 0.46d
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 10.65 ± 0.78c 5.56 ± 0.34c 5.93 ± 0.47d 4.94 ± 0.44c,d
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT). U= lmole of GSH
utilized/min.
Table 7 Effect of MME on levels of vitamin-E in the plasma and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Plasma (mg/dL) Vitamin-E (lg/mg protein)
Liver Kidney Heart
Sham-operated control 1.88 ± 0.12a 6.01 ± 0.43a 4.06 ± 0.34a 4.13 ± 0.36a
DOCA-salt + 1% NaCl control 0.96 ± 0.11b 3.45 ± 0.24b 1.52 ± 0.23b 1.67 ± 0.16b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 1.14 ± 0.16c 4.06 ± 0.26c 2.06 ± 0.19c 2.06 ± 0.26c
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 1.33 ± 0.14d 4.45 ± 0.29c 2.60 ± 0.19d 2.40 ± 0.12d
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 1.79 ± 0.11a 5.84 ± 0.32a 3.86 ± 0.24a 3.98 ± 0.25a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 1.51 ± 0.11e 4.92 ± 0.37d 2.96 ± 0.22e 2.87 ± 0.18e
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT).
Table 8 Effect of MME on levels of vitamin-C in the plasma and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Plasma (mg/dL) Vitamin-C (lg/mg protein)
Liver Kidney Heart
Sham-operated control 2.07 ± 0.12a 0.77 ± 0.06a 0.65 ± 0.03a 0.54 ± 0.03a
DOCA-salt + 1% NaCl control 0.91 ± 0.07b 0.56 ± 0.03b 0.39 ± 0.02b 0.27 ± 0.02b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 1.18 ± 0.11c 0.60 ± 0.04b,c 0.46 ± 0.03c 0.30 ± 0.03b
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 1.35 ± 0.10d 0.64 ± 0.06c 0.56 ± 0.04d 0.36 ± 0.03c
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 2.03 ± 0.15a 0.74 ± 0.06a,d 0.62 ± 0.05a 0.50 ± 0.04a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 1.82 ± 0.07e 0.69 ± 0.05c,d 0.57 ± 0.03d 0.45 ± 0.04d
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT).
Effects of Melothria maderaspatana leaf extract on antioxidant status in sham-operated 103cardiac and renal injury can be avoided or minimized by reduc-
ing oxidative stress through increased intake of antioxidants
(Schnackenberg et al., 1999). A few studies reported that anti-
oxidants such as vitamins and SOD normalize the endothelial
dysfunction and improves vascular remodeling in experimental
hypertension (Akpafﬁong and Taylor, 1998). Raja et al. re-
ported that M. maderaspatana possesses antioxidant property
in vitro (Raja and Pugalendi, 2009). Thus, the antihypertensive
effect of this extract may also be due to the decreased oxidative
stress and enhanced antioxidant potential of MME.
Oxidative stress, characterized by increased bioavailability
of reactive oxygen species (ROS), plays an important role in
the development and progression of cardiovascular dysfunc-
tion associated with hypertensive disease. Several studies have
been reported the increased level of ROS such as superoxide
anion, hydrogen peroxide and lipid peroxides in hypertensive
patients (Touyz, 2000). Salt-sensitive hypertension is character-
ized by endothelial dysfunction associated with increases inROS and local renin-angiotensin-aldosterone system activa-
tion (Zhou et al., 2003). In both spontaneously hypertensive
rat and DOCA–salt hypertension models, reactive oxygen spe-
cies production increased because of an increase in reduced
NADPH oxidase activity (Zalba et al., 2000). In this study,
the concentration of TBARS and LOOH signiﬁcantly in-
creased in the plasma and tissues of DOCA-salt rats as re-
ported earlier in clinical and experimental hypertensive rats
(Sundaram et al., 1996). The increased concentration of lipid
peroxidative markers suggests that an increase in oxygen free
radicals, either by increased production or decreased destruc-
tion (Kakkar et al., 1995). The levels of lipid peroxidative
markers in MME treated rats decreased signiﬁcantly, which
might be due to the presence of phenolic compounds such as
coumarins, ﬂavonoids, steroids and triterpenes (Sinha et al.,
1997; Bhattacharjee and Das, 1969). Earlier report also sup-
ports the in vitro antioxidant effect ofM. maderaspatana (Raja
and Pugalendi, 2009).
Table 9 Effect of MME on levels of GSH in the plasma and tissues of sham-operated and uninephrectomized DOCA-salt
hypertensive rats.
Name of the group Plasma (mg/dL) GSH (lg/mg protein)
Liver Kidney Heart
Sham-operated control 34.73 ± 2.99a 11.77 ± 1.03a 9.94 ± 0.53a 7.97 ± 0.41a
DOCA-salt + 1% NaCl control 21.86 ± 1.99b 7.73 ± 0.52b 4.65 ± 0.43b 3.78 ± 0.58b
DOCA-salt + 1% NaCl +MME (50 mg/kg BW) 23.28 ± 1.57b 8.10 ± 0.58b 5.39 ± 0.50b 4.26 ± 0.38b
DOCA-salt + 1% NaCl +MME (100 mg/kg BW) 26.31 ± 1.98c 8.65 ± 0.59b,c 6.45 ± 0.63c 5.12 ± 0.55c
DOCA-salt + 1% NaCl +MME (200 mg/kg BW) 32.64 ± 1.74a 10.07 ± 0.93d 9.01 ± 0.56a 7.20 ± 0.57a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 31.36 ± 1.94a 9.12 ± 0.62c,d 8.53 ± 0.68a,c 7.17 ± 0.63a
Values are means ± SD for six rats. Values not sharing a common superscript differ signiﬁcantly at p< 0.05 (DMRT).
104 C. Veeramani et al.Antioxidants inhibit lipid peroxidation (LPO) by prevent-
ing peroxidation chain reaction or accumulation of the ROS
(Bernard and Kathy, 2004). SOD, CAT and GPx are major
free radical scavenging enzymes that have shown to be reduced
in a number of pathophysiological processes and diseases such
as hypertension (Halliwell and Gutteridge, 1999). In the pres-
ent study, DOCA-salt rats caused a signiﬁcant depletion of
enzymatic antioxidants in erythrocyte and tissues. SOD is an
enzymatic antioxidant which reduces superoxide radical to
hydrogen peroxide. CAT is a heme protein located predomi-
nantly in peroxisomes and the inner mitochondrial membrane
that catalyzes the conversion of H2O2 to water and molecular
oxygen (Farombi et al., 2000). A decrease in the activities of
these antioxidant enzymes in tissue leads to the formation of
superoxide anion and hydrogen peroxide which can later form
hydroxyl radical. GSH-metabolizing enzyme, GPx, work in
concert with glutathione in the decomposition of hydrogen
peroxide and other organic hydroperoxides to non-toxic prod-
ucts. Reduced activity of GPx was observed due to inactiva-
tion of this enzyme by ROS. Treatment with MME show
increased activities of these enzymatic antioxidants, which
might be due to the presence of phenolic compounds. Thus,
administration of this extract clearly shows the free radical
scavenging activity, which could exert a beneﬁcial action
against pathophysiological alterations caused by superoxide
anion and hydroxyl radicals.
Non-enzymic antioxidants such as reduced glutathione,
vitamin C and vitamin E play an excellent role in protecting
the cells from oxidative damage.43 Vitamin E is a well-known
physiological antioxidant and membrane stabilizer. It inter-
rupts the chain reaction of lipid peroxidation by reacting with
lipid peroxy radicals, thus protecting the cell structures against
damage (Scibior et al., 2008). In our study, the level of vitamin
E decreased signiﬁcantly in DOCA-salt hypertensive rats
which may be due to the increased utilization for free radical
scavenging reaction or could be due to the decreased vitamin
C because there is a well established synergism between vita-
min C and E. Vitamin C is a hydrophilic antioxidant, because
it disappears faster than other antioxidants. In our study, vita-
min C level signiﬁcantly decreased in DOCA-salt rats which
might be caused by increased utilization of vitamin C as an
antioxidant defense against reactive oxygen species or by a de-
crease in GSH, which is required for the recycling of vitamin
C. GSH is one of the most important endogenous antioxi-
dants. It plays the role of a sulfhydryl (SH) group provider
for direct scavenging reactions. Glutathione peroxidase
(GPx) catalyzes peroxide reduction utilizing GSH as the
substrate and converting it to GSSG. Decreased GSH concen-tration may also contribute to decreased GPx activity because
GSH is one of the substrates for GPx (Asahi et al., 1995). In
our study, the plasma and tissue GSH concentration signiﬁ-
cantly decreased in DOCA-salt rats which may be due to an
increased utilization of GSH (Mahdi, 2002). The treatment
with MME has elevated the levels of these parameters in
DOCA-salt rats may be responsible for the decreased level of
lipid peroxidation.
In conclusions, the antihypertensive and antioxidant prop-
erties of MME support its ethno medical use in India. It can be
concluded that the M. maderaspatana leaf extract possesses
strong antihypertensive and antioxidant properties in
DOCA-salt hypertensive rats as evidenced by a signiﬁcant de-
crease the blood pressure and increase in the levels of enzy-
matic and non-enzymatic antioxidants.Acknowledgement
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